Cannabis Europa London returns on 26-27 May 2026, bringing together operators, investors, clinicians and policymakers from across the global cannabis industry for two days of main stage debate, exhibition, and networking.
In recent years, the pharmaceutical landscape has witnessed a seismic shift as cannabinoids transition from niche alternatives to mainstream medical solutions.
A new bill introduced this week that could have a significant impact on the ongoing battle to curb the spread of intoxicating hemp-derived products in the US.
The raise was co-led by DSM Venturing and Oskare Capital.
Helena Christensen will be the face of Cellular Goods’ new campaign.
The paper explores what Cellular Goods refers to as the ‘5 A’s of cannabinoid skincare’.
The research provides insight into how trichomes create high quantities of cannabinoids without the plant poisoning itself.
Open Book Extracts has partnered with developers of a proprietary chemical synthesis platform that produces ultra-pure, high quality, sustainable cannabinoids, Nalu Bio.
Broughton CEO Chris Allen spoke to Cannabis Wealth about the company’s ambitions to support safe and effective cannabinoid delivery.
